PREVALENCE OF ANTIBODIES TO HEPATITIS-C VIRUS IN HEMODIALYSIS-PATIENTS

被引：17

作者：

KALLINOWSKI, B ^{[1
]}

THEILMANN, L ^{[1
]}

GMELIN, K ^{[1
]}

ANDRASSY, K ^{[1
]}

DEPPERMANN, D ^{[1
]}

WEINEL, B ^{[1
]}

KOMMERELL, B ^{[1
]}

机构：

[1] UNIV HEIDELBERG,DEPT NEPHROL,W-6900 HEIDELBERG,GERMANY

来源：

NEPHRON | 1991年 / 59卷 / 02期

关键词：

ANTI-HCV; CHRONIC HEPATITIS; HEMODIALYSIS;

D O I：

10.1159/000186557

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Due to frequent parenteral contact with blood transfusions hemodialysis patients are prone to acquire hepatitis C virus (HCV) infection. To determine the role of HCV infection we investigated the prevalence of antibodies to HCV in 188 hemodialysis patients. The prevalence of antibodies to HCV was 7.4%. As compared to anti-HCV-negative patients, anti-HCV-positive patients had slightly elevated transaminases which were independent of the presence of markers for hepatitis B virus infection. We conclude that HCV infection is common among dialysis patients.

引用

页码：236 / 238

页数：3

共 18 条

[1] IMPACT OF INFECTION CONTROL STRATEGIES ON THE INCIDENCE OF DIALYSIS-ASSOCIATED HEPATITIS IN THE UNITED-STATES [J].

ALTER, MJ ;

FAVERO, MS ;

MAYNARD, JE .

JOURNAL OF INFECTIOUS DISEASES, 1986, 153 (06) :1149-1151

[2]

CHOO Q, 1989, SCIENCE, V244, P355

[3]

CONTRERAS M, 1989, LANCET, V2, P505

[4] T-LYMPHOCYTE NUMBER AND FUNCTION AND COURSE OF HEPATITIS B IN HEMODIALYSIS PATIENTS [J].

DEGAST, GC ;

HOUWEN, B ;

VANDERHEM, GK ;

THE, TH .

INFECTION AND IMMUNITY, 1976, 14 (05) :1138-1143

[5]

ESTEBAN JI, 1989, LANCET, V2, P294

[6]

GETZUG T, 1990, GASTROENTEROLOGY, V8, P1395

[7]

GMELIN K, 1982, ZBL BAKT MIK HYG B, V176, P28

[8]

GROB PJ, 1990, SCHWEIZ MED WSCHR, V120, P117

[9]

JAKOBS C, 1977, 14TH P C EUR DIAL TR

[10]

JANOT C, 1989, LANCET, V2, P796

← 1 2 →